FYI – early days but interesting possibilities for combined use of biomarker assays resulting in high specificity in both early OA and early RA (87% and 91%, respectively) – good sensitivity in OA (73%), compared with healthy controls and patients without RA. Ahmed U, Anwar A, Savage RS, et al., Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal Health.
Here is the original post:
Future Blood Test for Osteoarthritis?
